LINEZOLID AMNEAL linezolid 600 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid amneal linezolid 600 mg tablet bottle

amneal pharma australia pty ltd - linezolid, quantity: 600 mg - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; ethylcellulose; silicon dioxide; povidone; microcrystalline cellulose; diethyl phthalate; purified talc - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. it has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

LINEZOLID CA linezolid 600 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid ca linezolid 600 mg film-coated tablet bottle

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; maize starch; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid ca is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid ca is active against gram-positive bacteria only. ,linezolid ca has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

LINEZOLID CA linezolid 600 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid ca linezolid 600 mg film-coated tablet blister pack

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid ca is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid ca is active against gram-positive bacteria only. ,linezolid ca has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

LINEZOLID PANPHARMA INJECTION linezolid 600 mg in 300 mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 600 mg in 300 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID PANPHARMA INJECTION linezolid 400 mg in 200 mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 400 mg in 200 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 400 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID PANPHARMA INJECTION linezolid 200 mg in 100 mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 200 mg in 100 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 200 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bottle

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: sodium citrate; sodium hydroxide; glucose monohydrate; citric acid; hydrochloric acid; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bag

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium citrate; citric acid; sodium hydroxide; water for injections; glucose monohydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID CIP linezolid 600 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid cip linezolid 600 mg film-coated tablet blister pack

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid cip is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid cip is active against gram-positive bacteria only.,linezolid cip has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

LINEZOLID CIP linezolid 600 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid cip linezolid 600 mg film-coated tablet bottle

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: maize starch; hyprolose; sodium starch glycollate type a; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid cip is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid cip is active against gram-positive bacteria only.,linezolid cip has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.